Psoriasis Cream Dr. DERM, developed by professional dermatologists, treats psoriasis symptoms while moisturizing and rebuilding the skin's protective barrier. An anti-psoriasis drug removes scales and dead cells and helps restore skin moisture, preventing psoriasis symptoms from recurring. The use of the medicine helps to quickly stop the aggravated symptoms and cure psoriasis within a short course.
Pre-cleanse skin with a neutral lotion. Apply Dr. DERM to affected areas one to four times daily or as directed by a healthcare practitioner. You can also view the patient information included with the product.
Instructions for applying the preparation:
Inflamed skin is sensitive to UV rays. Avoid direct sunlight on wounds during therapy. Use sunscreen, wear protective clothing, and limit sun exposure while using Dr. DERM and within a week after the completion of treatment procedures. The recommended course of therapy is 28 days. Doctors advise to repeat the treatment after 2-3 months for the purpose of prevention.
|Week 1||The cream removes inflammation, itching, flaking, plaques.|
|Week 2||The process of regeneration of damaged tissue is started due to the normalization of the cell division cycle.|
|Week 3||The pH of the body is normalized, the skin tone is increased. The skin becomes firm and elastic.|
|Week 4||If you follow a diet, the disease will not worsen.|
Dr. DERM is indicated for the treatment of mild to moderate psoriasis. The drug reduces inflammation, reduces itching and slows down cell production. Types of psoriasis for which the use of the cream is recommended:
Dr. DERM should be applied directly to the affected area when undergoing treatment or when symptoms are flaring.
The drug against psoriasis Dr. DERM is based on natural hypoallergenic components and does not cause side reactions. The use of the medicine is not recommended in the following cases:
Care should be taken to use the cream if there is a pronounced allergic reaction to the components of the drug. The drug has passed all stages of clinical trials in laboratory conditions in Germany.